Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia

Antonella Tosti, B. M. Piraccini, M. Soli

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background. Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia®) for androgenetic alopecia are much less common than reported in the literature. Objective. To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF). Methods. The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia® and 236 age-matched males attending the Department of Dermatology of the University of Bologna. Results. Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls. Conclusions. The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia®.

Original languageEnglish
Pages (from-to)418-421
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Volume15
Issue number5
DOIs
StatePublished - Nov 20 2001
Externally publishedYes

Fingerprint

Finasteride
Alopecia
Therapeutics
Erectile Dysfunction
Dermatology

Keywords

  • Hair loss
  • International Index of Erectile Function (IIEF)
  • Male pattern baldness
  • Treatment

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia. / Tosti, Antonella; Piraccini, B. M.; Soli, M.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 15, No. 5, 20.11.2001, p. 418-421.

Research output: Contribution to journalArticle

@article{2b8084b80ebe4bdaa0ba4b708fd1583d,
title = "Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia",
abstract = "Background. Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia{\circledR}) for androgenetic alopecia are much less common than reported in the literature. Objective. To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF). Methods. The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia{\circledR} and 236 age-matched males attending the Department of Dermatology of the University of Bologna. Results. Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls. Conclusions. The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia{\circledR}.",
keywords = "Hair loss, International Index of Erectile Function (IIEF), Male pattern baldness, Treatment",
author = "Antonella Tosti and Piraccini, {B. M.} and M. Soli",
year = "2001",
month = "11",
day = "20",
doi = "10.1046/j.1468-3083.2001.00315.x",
language = "English",
volume = "15",
pages = "418--421",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia

AU - Tosti, Antonella

AU - Piraccini, B. M.

AU - Soli, M.

PY - 2001/11/20

Y1 - 2001/11/20

N2 - Background. Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia®) for androgenetic alopecia are much less common than reported in the literature. Objective. To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF). Methods. The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia® and 236 age-matched males attending the Department of Dermatology of the University of Bologna. Results. Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls. Conclusions. The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia®.

AB - Background. Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia®) for androgenetic alopecia are much less common than reported in the literature. Objective. To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF). Methods. The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia® and 236 age-matched males attending the Department of Dermatology of the University of Bologna. Results. Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls. Conclusions. The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia®.

KW - Hair loss

KW - International Index of Erectile Function (IIEF)

KW - Male pattern baldness

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0034766314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034766314&partnerID=8YFLogxK

U2 - 10.1046/j.1468-3083.2001.00315.x

DO - 10.1046/j.1468-3083.2001.00315.x

M3 - Article

C2 - 11763381

AN - SCOPUS:0034766314

VL - 15

SP - 418

EP - 421

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 5

ER -